Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of the NT-501 Intraocular Implant Releasing Ciliary Neurotrophic Factor (CNTF) in Participants With CNGB3 Achromatopsia

NCT01648452 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT01648452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01648452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of the NT-501 Intraocular Implant Releasing Ciliary Neurotrophic Factor (CNTF) in Participants With CNGB3 Achromatopsia
Lead sponsor
National Eye Institute (NEI)
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2012
Completion date
October 31, 2015
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

achromatopsia, eye disease